secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001171843-24-002669
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cassava Sciences raises over $125M from warrant exercises; ~5.7M shares at $22
------------------------------------------------------------------------------

- Gross proceeds over $125M from cash exercises of warrants; ~5.7M common shares issued at $22.00 per share.
- Net proceeds estimated at over $123M after advisory fees and expenses.
- Proceeds to fund working capital and continued development of Alzheimer's drug simufilam.
- Warrants distributed to shareholders, last exercise deadline May 6, 2024; remaining warrants redeemed at $0.001 each.
- B. Dyson Capital Advisors acted as exclusive financial advisor on the warrant distribution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000117184324002669/0001171843-24-002669-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000117184324002669/f8k_050824.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-002669

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer